NASDAQ:ALLO | Net Income | Allogene Therapeutics, Inc.

Complete source-backed net income history.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical Net Income

DateNet Income
2026-06-30-$42.68M
2026-03-31-$42.61M
2025-12-31-$38.81M
2025-09-30-$41.4M
2025-06-30-$50.94M
2025-03-31-$59.73M
2024-12-31-$59.94M
2024-09-30-$66.29M
2024-06-30-$66.36M
2024-03-31-$65M
2023-12-31-$85.78M
2023-09-30-$62.29M
2023-06-30-$79.23M
2023-03-31-$99.97M
2022-12-31-$97.28M
2022-09-30-$83.15M
2022-06-30-$74.79M
2022-03-31-$79.85M
2021-12-31$86,000.00
2021-09-30-$78.19M
2021-06-30-$70.94M
2021-03-31-$33.02M
2020-12-31-$68.57M
2020-09-30-$66.2M
2020-06-30-$60.97M
2020-03-31-$54.48M
2019-12-31-$61.03M
2019-09-30-$50.74M
2019-06-30-$41.24M
2019-03-31-$31.59M
2018-12-31-$30.51M
2018-09-30-$43.5M
2018-06-30-$134.9M
2018-03-31-$2.6M

Annual Net Income

DateNet Income
2025-12-31-$190.89M
2024-12-31-$257.59M
2023-12-31-$327.27M
2022-12-31-$340.41M
2021-12-31-$182.05M
2020-12-31-$250.22M
2019-12-31-$184.59M
2018-12-31-$211.51M